Our Mission
| Abiant's mission is to accelerate the diagnosis and development of improved therapeutics through imaging. PET imaging and complementary imaging modalities provide a powerful window to drug action that can facilitate decisions earlier in drug development. Abiant's team has dedicated its efforts and technology to making the use of PET imaging reliable, practical, and informative for pharmaceutical decision-making. |
 | |  | |  | |  |
About Us
Advanced BioImaging to Accelerate New Therapeutics
| There are over 5 million people with Alzheimer's Disease, 19 million with depression, 2 million with schizophrenia, and many more in the U.S. alone... It is Abiant's goal that our efforts, combined with those of our customers and partners, will make a difference. |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| |
 |
| Copyright 2006-2009 Abiant, Inc. |